Title |
Therapeutic approaches for corneal neovascularization
|
---|---|
Published in |
Eye and Vision, December 2017
|
DOI | 10.1186/s40662-017-0094-6 |
Pubmed ID | |
Authors |
Sepehr Feizi, Amir A. Azari, Sharareh Safapour |
Abstract |
Angiogenesis refers to new blood vessels that originate from pre-existing vascular structures. Corneal neovascularization which can lead to compromised visual acuity occurs in a wide variety of corneal pathologies. A large subset of measures has been advocated to prevent and/or treat corneal neovascularization with varying degrees of success. These approaches include topical corticosteroid administration, laser treatment, cautery, and fine needle diathermy. Since the imbalance between proangiogenic agents and antiangiogenic agents primarily mediate the process of corneal neovascularization, recent therapies are intended to disrupt the different steps in the synthesis and actions of proangiogenic factors. These approaches, however, are only partially effective and may lead to several side effects. The aim of this article is to review the most relevant treatments for corneal neovascularization available so far. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
India | 1 | 20% |
Italy | 1 | 20% |
Unknown | 3 | 60% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 91 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 9% |
Other | 7 | 8% |
Researcher | 6 | 7% |
Student > Postgraduate | 6 | 7% |
Student > Doctoral Student | 5 | 5% |
Other | 19 | 21% |
Unknown | 40 | 44% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 24% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 7% |
Biochemistry, Genetics and Molecular Biology | 6 | 7% |
Unspecified | 3 | 3% |
Neuroscience | 3 | 3% |
Other | 8 | 9% |
Unknown | 43 | 47% |